| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
David Main last filed a Form 4 in August 2018, as President and CEO at NGNE. David Main's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 71,530 shares of NGNE. The NGNE filings lean toward selling, a net 15,625 shares.
David Main has 6 Form 4 filings on record from March 2015 to August 2018, all as President and CEO at Neurogene (NGNE), 2015–2018.
The 11 reported transactions were 5 option or other derivative awards, 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $207K.
The only open-market sale was 15,625 shares of NGNE at an average $13.26 on June 5, 2017, about $207K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2017 | NGNE Neurogene Inc. | President and CEO | Sale+OE | 15,625 | $13.26 | $207,243.74 | -17.9% |